©Institut du Cerveau - ICM

Open / close summary

Every 5 years, Paris Brain Institute as a joint research unit (UMR) is assessed on the quality of its research, its organization, its strategy and  its  five-year  scientific  strategy.  Team  research  projects  are assessed by the International Scientific Advisory Board (SAB), whose mission is to advise the Institute and assist it in defining its general orientations. After discussion, the SAB submits an opinion that is taken into account to build the file submitted for evaluation by  the  High  Council  for  the  Evaluation  of  Research  and  Higher Education (HCERES).

Pr Michael Shelanski – President

President of the SAB, Columbia University, New York, USA


Pr Dimitri Kullman

ION, University College of London, UK


Pr Gabor Tamas

Research Group for Cortical Microcircuits of the Hungarian Academy of Sciences Department of Physiology, Anatomy and Neuroscience, University of Szeged, Hungary


Pr Peter Brown

Division of Clinical Neurology Nuffield Department of Clinical Neurosciences, Oxford, UK


Pr Brad Hyman

Massachusetts Alzheimer Disease Research Center, USA


Pr Stephen Hauser

UCSF, Sandler Institute, USA


Pr Bill Richardson

UCL London, UK


Pr Helen Mayberg

Center for Advanced Circuit Therapeutics, USA


Pr Christian Buchel

University Medical Centre Hamburg-Eppendorf – Department of Systems Neuroscience, Germany


Pr Arnold Kriegstein

UCSF, San Fransisco, USA


Pr Masud Husain

University of Oxford, UK


Pr Michael Heneka

University of Bonn, DZNE, Germany